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Summary: Seasonal ataxia was reported in humans following the consumption   of Anaphe venata larva as protein 
supplement in diet and altered motor function in rodents when the extract was administered intraperitoneally.  In this study 
we investigated the effect of the crude aqueous and Phosphate Buffer Saline (PBS) extracts of this larva on altered 
spontaneous rat behavior in a novel environment particularly chewing behaviour, with a view to determine the 
mechanism(s) involved in these behavioural alteration. Animals were randomly assigned into four groups (n = 6-12 per 
group) and graded doses of aqueous and PBS extracts (100-400 mg/kg) were administered dissolved in saline 
intraperitoneally (i.p.) to each animal in the experimental groups. The control group received an equivalent volume of 
saline. Behavioral scores were recorded for a period of 30 minutes after the administration of saline or extract. The role of 
various receptors in the extract induced chewing was evaluated using known receptor agonist/antagonists. Results revealed 
a significant increase in purposeless chewing (F (7, 95) = 7.85; p<0.05) by the aqueous extract compared to saline control at 
all dose levels, which was significantly attenuated by scopolamine (3 mg/kg, i.p) and thiamine (1 mg/kg, i.p) respectively 
(p<0.05); while flumazenil (2 mg/kg, i.p) and naloxone (2.5 mg/kg, i.p) did not alter the induced purposeless chewing 
behaviour. Also, administration of PBS induced  a significant (F (7, 95) = 6.11; p<0.05) increase in chewing behaviour but 
only at 400 mg/kg dose level which was attenuated by scopolamine (3 mg/kg, i.p); while flumazenil (2 mg/kg, i.p), 
naloxone (2.5 mg/kg, i.p), and thiamine (1 mg/kg, i.p) potentiated purposeless chewing behaviour respectively. It may 
therefore be concluded from this study that Anaphe extract-induced purposeless chewing behaviour in rat is mediated via 
the activation of cholinergic neurotransmission which is modulated by GABAergic and opioid receptor systems. 
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Seasonal ataxia was reported in humans following the 
ingestion of roasted larvae of Anaphe venata. The 
disease, onset is acute postprandial and presents with 
a triad of cerebellar ataxia, intention tremors, and 
other motor abnormalities (Adamolekun, et al., 
1994). 
       Anaphe venata (Lepidoptera, Notodontidae), a 
moth reported to occur mainly in Africa. Its larva is a 
defoliator of Triplochiton scleroxylon K. Schum 
(Obeche); an economically important timber species 
in Nigeria. The Anaphe venata larva referred to as 
African Silkworm, is eaten in some part of Western 
Nigeria particularly among Ijesa people as a 
culturally acceptable means of dietary protein 
supplementation (Golding, 1942; Umoh et al., 1980; 
Ashiru, 1988) which is widely available in the raining 
season (July-September) (Adamolekun, 1993; 
Adamolekun et al., 1994).  
 The larva is reported to be of high protein content 
(Umoh et al., 1980; Ashiru, 1988). Available data on 
the chemical constituents of A. venata larvae revealed 
the presence of amino acids, fats, proteins and sterols 
( Onayade and Adamolekun, 1996); existence of 
thiaminase type I enzyme has also been confirmed by 
some Japanese researchers (Nishimune et al., 2000) 
supporting the earlier proposal of Adamolekun 
(1993). In view of the above findings, the 
phenomenon of acute seasonal ataxic syndrome raises 
an issue of public health importance. This serves as 
impetus to investigate the behavioural effects of the 
extract of this larva in animals. Initial investigations 
in rodents using the extract of this larva showed that 
extract of this larva induced some behavioral 
alterations characterized by motor disturbances 
among which is alteration in novelty-induced 
behaviours like purposeless chewing, stretching and 
ataxia in animals (Onayade et al., 2004; Iwalewa et 
al., 2005).  But the neuropharmacological 
mechanism(s) of these behaviours has not been 
explored. Our study therefore examined the 
neuropharmacological mechanisms involved in the 
Anaphe venata extract induced purposeless chewing 
behaviour in the rats 
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MATERIALS AND METHODS 
 
Preparation of Anaphe venata extracts 
Dried Anaphe venata larvae were purchased from the 
market at Ile-Ife, Osun State and authentication was 
done by Professor W. A. Muse in the Department of 
Zoology, Obafemi Awolowo University, Ile-Ife, 
Nigeria.  
        The powdered larvae (150 g) were extracted 
cold in 2 litres of water with continuous shaking for 
24 hours in a mechanical shaker. The mixture was 
filtered and then freeze-dried to obtain the crude 
aqueous extract. The total aqueous extract obtained 
was 6.5 g (4.3% yield w/w). Phosphate Buffer Saline 
(PBS) extract of the larvae was obtained by soaking 
225 g of powdered larvae in 1.5 litres of freshly 
prepared Phosphate Buffer Saline (PBS) at pH 7.4 
and kept in the refrigerator for 12 hours. The extract 
was filtered and the filtrate centrifuged at 15,000 x g 
for 10 minutes at 4 ºC (IEC B-20A Centrifuge, 
Damon/IEC Division U.S.A). The resulting 
supernatant, freeze-dried to obtain the crude PBS 
extract (SB-4 Freeze-dryer, Benhay, SB4, UK). The 
total amount of crude PBS extract obtained was 
16.128 g (7.1% yields w/w). 
 
Animals  
Male Wistar rats (Vom strains), obtained from 
College of Health Sciences Animal House, Obafemi 
Awolowo University Ile-Ife, Nigeria were used for all 
investigations and were fed with Guinea Feed 
Growers (Bendel Feeds and Flour Mills, Ewu Edo 
State, Nigeria), water available ad libitium. 
 
Drugs: Scopolamine Hydrochloride, Naloxone 
Hydrochloride, Flumazenil, Thiamine hydrochloride 
(Sigma-Aldrich, St Louis, USA). 
 
Observation cage: Plexiglas observation cage (45 x 
25 x 25 cm) with only one side transparent for 
observation. 
 
The general protocol for the behavioural assays 
Rats were placed directly from their home 
cage into an opaque Plexiglas observation cage (45 x 
25 x 25 cm) with only one side transparent for 
observation. All animals were observed and scored 
singly in the cage after the administration of the test 
substance or saline. Each animal was used only once 
with wood shavings bedding changed after each 
assessment to remove olfactory cue from one animal 
to the other (Brown et al., 1999). All experiments 
were carried out between 10.00 a.m-2.00 p.m. daily 
to avoid behavioural variations due to circadian 
rhythm (Siquera et al., 1998). The laboratory was 
brightly lit, with an ambient temperature of 27 ± 2ºC. 
All animals were randomly assigned into groups 
consisting of 6-12 rats per group. The scoring for 
each parameter was done over a period of 30 minutes 
for each animal. All Investigations were conducted in 
accordance with the internationally accepted 
principles for laboratory animal use (EEC Directive 
of 1986; 86/609/EEC). 
 
Assessment of effect of Anaphe extracts and 
antagonists on purposeless chewing 
 The animals were randomly assigned into 4 
groups and graded doses (100, 200, 400 mg/kg, i.p.) 
of aqueous and PBS Anaphe extracts were 
administered in normal saline to each animal 
respectively while equal volume (1 ml/kg, i.p.) of 
normal saline were administered to the control group. 
Effect of pretreatment with scopolamine (3 mg/kg), 
flumazenil (2 mg/kg), naloxone (2.5 mg/kg) and 
thiamine (1 mg/kg) 15 min prior to extract 
administration respectively on chewing were also 
evaluated. Purposeless chewing was assessed by 
direct observation and counting the number of chews 
following drugs/extracts administration. Purposeless 
chewing was defined as rapid, repetitive vertical 
deflections of the lower jaw that resembles chewing 
but not directed at any object; each individual 
deflections of the jaw was counted as a single jaw 
movement ( Mayorga et al., 1999)  
 
Statistical Analysis 
Each value was expressed as mean ± SEM. 
Significance changes in purposeless chewing 
following various treatment was analyzed using one-
way analysis of variance (ANOVA) followed by 
Student-Neuman-Keuls test. P-value equal to or less 
than 0.05 was taken as significant. Data management 
was carried out using Primer of Biostatistics 




ANOVA revealed a significant increase in 
purposeless chewing (F (7, 95) = 7.85; p<0.05) by the 
aqueous extract compared to saline control at all dose 
levels. Similarly ANOVA revealed a significant (F (7, 
95) = 6.11; p<0.05) increase in chewing behaviour by 
the PBS extract but only at 400 mg/kg dose level. 
Effect of the various individual antagonists on the 
extract induced chewing behaviour is as follows: 
 
a.) Aqueous Anaphe extract + antagonist: 
i. Scopolamine (3 mg/kg, i.p) attenuated the dose-
dependent increase in purposeless chewing 
significantly (p< 0.05) at all doses used (fig. 1). 
 Nig. J, Physiol. Sci. 25 (2010): Bamitale, Akanmu and Ukponmwan 
53 
 
ii. Thiamine (1 mg/kg, i.p) attenuated the dose-
dependent purposeless chewing significantly (p< 
0.05) at the highest dose of 400 mg/kg of the 
extract (fig. 4). 
iii. Flumazenil (2 mg/kg, i.p) did not have any effect 
on the extract induced purposeless chewing 
behaviour (fig. 2). 
iv. Naloxone (2.5 mg/kg, i.p) did not have any 
effect on the extract induced purposeless 





Fig. 1     
Effect of aqueous Anaphe extract and Scopolamine on chewing behaviour. Each bar is expressed as Mean ± SEM.; (n =12) 
per treatment group. One-way ANOVA revealed significant differences between the control and the treatment groups F (7, 
95) = 7.85; p<0.05. The extract at 100, 200, and 400 mg/kg induced significant chewing behaviour in rat compared to saline 
control. Scopolamine (3 mg/kg, i.p), attenuated extract- induced   chewing behaviour.  # p<0.05: Anaphe extract vs Saline 




Fig. 2  
Effect of aqueous Anaphe extract and flumazenil on chewing behaviour Each bar is expressed as Mean ± SEM.; (n =8-12) 
per treatment group. One-way ANOVA revealed significant differences between the control and the treatment groups F (7, 
79) = 1.97; p<0.05. The extract at 100, 200, and 400 mg/kg induced significant chewing behaviour in rat compared to saline 
which was not altered by flumazenil (2 mg/kg, i.p).  # p<0.05: Anaphe extract vs Saline control 





Fig.3   
Effect of aqueous Anaphe extract and naloxone on chewing behaviour.. Each bar is expressed as Mean ± SEM.; (n =8-12) 
per treatment group. One-way ANOVA revealed no significant differences between the control and the treatment groups F 
(7, 79) = 1.31; p<0.05. The extract at 100, 200, and 400 mg/kg induced significant chewing behaviour in rat compared to 





Effect of aqueous Anaphe extract and thiamine on chewing behaviour.. Each bar is expressed as Mean ± SEM.; (n = 6-12) 
per treatment group. One-way ANOVA revealed significant differences between the control and the treatment groups F (7, 
71) = 2.11; p<0.05. The extract at 100, 200, and 400 mg/kg induced significant chewing behaviour in rat compared to saline 
p<0.05, which was attenuated by thiamine (1 mg/kg, i.p). But also thiamine alone increased chewing behaviour in rat 
compared to saline.  # p<0.05: Anaphe extract vs Saline control; * p<0.05: Anaphe extract vs. Anaphe + thiamine.  
 
 
b.) PBS Anaphe extract + antagonist 
i. Scopolamine (3 mg/kg, i.p) attenuated the dose-
dependent increase in purposeless chewing 
significantly (p< 0.05) at the dose of 200 mg/kg 
and 400 mg/kg respectively (fig. 5). 
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ii. Flumazenil (2 mg/kg, i.p) significantly (p<0.05) 
potentiated the extract induced purposeless 
chewing behaviour at the dose 200 mg/kg and 
400 mg/kg respectively (fig. 6). 
iii. Naloxone (2.5 mg/kg, i.p) significantly (p<0.05) 
potentiated the extract induced purposeless 
chewing behaviour at the dose 200 mg/kg and 
400 mg/kg respectively (fig. 7). 
iv. Thiamine (1 mg/kg, i.p) significantly (p<0.05) 
potentiated the extract induced purposeless 
chewing behaviour at the dose 200 mg/kg and 




Anaphe extracts induced significant purposeless 
chewing in the animals compared to saline control. In 
this study it was observed that aqueous extract was 
more effective in inducing purposeless chewing as all 
doses used produced significant increase in chewing 
while chewing was only significant at the maximum 
dose used with PBS extract.   
 
 
Fig. 5  
Effect of PBS Anaphe extract and scopolamine on chewing behaviour.. Each bar is expressed as Mean ± SEM.; (n =6-12) 
per treatment group. One-way ANOVA revealed significant differences between the control and the treatment groups F (7, 
59) = 6.11; p<0.05. The extract at 100, 200, and 400 mg/kg induced chewing behaviour in rat compared to saline which was 




Fig.6    
Effect of PBS Anaphe extract and flumazenil on chewing behavior. Each bar is expressed as Mean ± SEM.; (n =6-12) per 
treatment group. One-way ANOVA revealed significant differences between the control and the treatment groups F (7, 55) = 
7.16; p<0.05. The extract at 100, 200, and 400 mg/kg induced chewing behaviour in rat compared to saline control which 
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was potentiated by flumazenil (2 mg/kg, i.p). # p<0.05: Anaphe extract vs saline control; * p<0.05: Anaphe extract vs. 
Anaphe + flumazenil. 
 
Fig.7  
Effect of PBS Anaphe extract and naloxone on chewing behaviour. Each bar is expressed as Mean ± SEM.; (n =6-12) per 
treatment group. One-way ANOVA revealed significant differences between the control and the treatment groups F (7, 53) = 
13.51; p<0.05. The extract at 100, 200, and 400 mg/kg induced chewing behaviour in rat compared to saline control which 
was potentiated by naloxone (2.5 mg/kg, i.p).  # p<0.05: Anaphe extract vs saline control; * p<0.05: Anaphe extract vs. 





Effect of PBS Anaphe extract and thiamine on chewing behaviour. Each bar is expressed as Mean ± SEM.; (n 
=6-12) per treatment group. One-way ANOVA revealed significant differences between the control and the 
treatment groups F (7, 53) = 7.45; p<0.05. The extract at 100, 200, and 400 mg/kg induced chewing behaviour in 
rat compared to saline control which was potentiated by thiamine (1 mg/kg, i.p). # p<0.05: Anaphe extract vs 
saline control; * p<0.05: Anaphe extract vs. Anaphe + thiamine. 
 
This action was attenuated by scopolamine (a 
muscarinic antagonist) in the presence of both 
extracts, suggesting a central cholinergic (muscarinic) 
receptor involvement. Chewing mouth movement had 
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previously been attributed to direct activation of 
central cholinergic neurons (Rupniak et al., 1984; 
Stoessl et al., 1988) and therefore a useful index of 
agonist action at the central muscarinic receptors 
(Salamone et. al., 1986). 
 However, it is interesting to note that scopolamine 
blocked chewing induced by both extracts which 
suggests that this extract acts via cholinergic 
muscarinic receptors to induce chewing similar to the 
mechanism involved in chewing behaviour as 
previously reported in the rat ( Mayorga et al., 1999). 
Thiamine behaved differently in both 
extracts; it exhibited blockade with aqueous extract 
which may be its direct blockade of the cholinergic 
neurotransmission (Harley and Flesher, 1946). On the 
other hand, it facilitated chewing with PBS extract 
which may probably be attributable to its central 
cholinomimetic effect (Meador et al., 1993) and its 
anticholinesterase activity (Rodgriguez-Martin et al., 
2001).  
Flumazenil (a GABA antagonist) and 
naloxone (an opioid antagonist) did not alter the 
extract-induced chewing with aqueous extract 
administration, which suggests that GABA and 
opioid systems were not involved in the aqueous 
extract induced chewing. However, flumazenil and 
naloxone potentiated chewing respectively with PBS 
extract, which may be a modulatory action of GABA 
and opioid receptors respectively on the cholinergic 
neurons (Cousins et al., 1999; Tien et al., 2004). The 
presence of cholinergic cells which serves as 
interneurons in the striatal brain area has been 
reported (Woolf, 1991) which are said to play a role 
in motor function which is involved in chewing 
behaviour and that they interact with other 
neurotransmitter systems such as GABAergic (Sivam 
et al., 1983; Harsing and Zigmond, 1998) and opioid 
systems (Tien et al., 2004).  
In conclusion, our study therefore suggested 
that Anaphe extract-induced purposeless chewing 
behaviour in rat is mediated via the activation of 
cholinergic neurotransmission which is modulated by 
GABAergic and opioid receptor systems. 
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